GROWING MEDICAL DEVICE SALES

WITH OUTSTANDING COMPLIANCE & COMMERCIAL EXPERTISE

Asia Actual is a leading medical device regulatory consulting company providing customized market access solutions through registration, independent license holding, and importing support services to all medical device manufacturers, including software, novel, and high-risk devices.

We distinguish ourselves with (1) outstanding personnel; (2) clear communication; and  (3) transparent operations. We have offices staffed by experienced, bilingual regulatory and commercial professionals in the major capital cities of Asia.

Our mission is to provide a stable, reliable local platform so that our clients can grow their sales in challenging Asian markets.

Let Us Help You Grow Your Sales.

Browse all countries

Speak to a Local Regulatory Professional Today

Contact Us

Meet our Experts

BRYAN GILBURG

MANAGING DIRECTOR
(USA)

GUNJAN VERMA

MANAGING PARTNER
(INDIA)

ILHAM HIDAYATTULAH

PRINCIPAL CONSULTANT
(INDONESIA)

CHARMAINE ROSON

PRINCIPAL CONSULTANT
(PHILIPPINES)

Glend Llantada

IMPORTATION SPECIALIST
(SOUTHEAST ASIA)

SAYOOMPORN (NOI) SUWANNABOT

GENERAL MANAGER
(THAILAND)

ERIC LEUNG

GENERAL MANAGER
(HONG KONG AND TAIWAN)

SARAH BAIK

PRINCIPAL CONSULTANT
(KOREA)

DAVID VO

GENERAL MANAGER
(VIETNAM)

KENNA RASIKLAL

PRINCIPAL CONSULTANT
(SINGAPORE)

ALBERT PRANOTO

HEAD OF BUSINESS DEVELOPMENT - ASIA (SINGAPORE)

The future is bright.

Asia Actual’s innovative approach of leveraging regulatory compliance to create novel sales channel management tools has made us the fastest growing consultancy in the region. The formula is a winning one. Come grow with us.

We represent over 100 Dynamic companies from 20 Countries
with over

1,000 registered products

to date

Search Our Regulatory Knowledge

Recent News from Asia

CDSCO Issues Updates to IVD Classification List in India

The Central Drugs Standard Control Organisation (CDSCO) of India issued a notice (PDF) on October 25, 2023 classifying in-vitro diagnostic (IVD) medical devices under medical device rules. The updates to IVD classification in India include intended use, associated risk, and other parameters.
Read more

Embracing Innovation and Collaboration: Highlights from the 15th CII Global MedTech Summit

On October 6, 2023, a team of enthusiastic members from the AAI (Artificial Intelligence and Innovation) group, including Ashoniya Puri, Sanjay Singh, and Rajat Budhori, had the honor of attending the prestigious 15th CII Global MedTech Summit. Hosted by the Confederation of Indian Industry (CII), one of India's largest industry bodies, this event brought together key players in the MedTech sector, both from India and abroad. The summit revolved around the central theme, "Paving the way for a USD 50 billion MedTech Industry by 2030," signifying a collective vision for the industry's future growth.
Read more

Bangladesh LAUNCHES NEW MEDICAL DEVICE REGULATIONS

On September 18, 2023, The Directorate General of Drug Administration (DGDA) published the Drug and Cosmetics Act 2023 formalizing the regulatory requirements of medical and diagnostic devices in Bangladesh with immediate effect.  A translated version of the document is available on Asia Actual’s website here.  All medical devices now require a Marketing Authorization Certificate to clear Customs and be sold on the market in Bangladesh.
Read more

Sign Up For Our Newsletter to Stay Informed

Sign Up